Publications by authors named "Kevin Klos"

Claim this Profile
S
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Andrew McGarry, Shane Rosanbalm, Mika Leinonen, C Warren Olanow, Dennis To, Kevin Klos

Lancet Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT Agonist, in Patients With Parkinson Disease Psychosis: A Pilot Study.
Stuart H Isaacson, Mark Goldstein, Rajesh Pahwa, Carlos Singer, Kevin Klos

Neurol Clin Pract· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.
Michael Camilleri, Thyagarajan Subramanian, Fernando Pagan, Stuart Isaacson, Ramon Gil, Kevin Klos

Ann Intern Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.
Michael J Soileau, Jason Aldred, Kumar Budur, Nahome Fisseha, Victor Sc Fung, Kevin Klos

Lancet Neurol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson's disease starting transdermal rotigotine patch: A pilot study.
Stuart H Isaacson, Babak Boroojerdi, Olga Waln, Martha McGraw, David L Kreitzman, Kevin Klos

Parkinsonism Relat Disord· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: DUOPA® is an Excellent Alternative Treatment but with Some Caveats.
Michelle Burack, Jason Aldred, Cindy Zadikoff, Arvydas Vanagunas, Kevin Klos

Mov Disord Clin Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners.
Michelle Burack, Jason Aldred, Cindy Zadikoff, Arvydas Vanagunas, Kevin Klos

Mov Disord Clin Pract· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.
Alberto J Espay, Fernando L Pagan, Benjamin L Walter, John C Morgan, Lawrence W Elmer, Kevin J Klos

Neurol Clin Pract· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

JAMA· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?
Roberta Frigerio, Hiroshige Fujishiro, Tae-Beom Ahn, Keith A Josephs, Demetrius M Maraganore, Kevin J Klos

Neurobiol Aging· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropathology of non-motor features of Parkinson disease.
Dennis W Dickson, Hiroshige Fujishiro, Carolyn Orr, Anthony DelleDonne, Keith A Josephs, Kevin J Klos

Parkinsonism Relat Disord· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.
Roberta Frigerio, Hiroshige Fujishiro, Demetrius M Maraganore, Kevin J Klos, Anthony DelleDonne

Arch Neurol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidental Lewy body disease and preclinical Parkinson disease.
Anthony DelleDonne, Kevin J Klos, Hiroshige Fujishiro, Zeshan Ahmed, Joseph E Parisi

Arch Neurol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease.
Hiroshige Fujishiro, Roberta Frigerio, Melinda Burnett, Kevin J Klos, Keith A Josephs

Mov Disord· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
Dennis W Dickson, Hiroshige Fujishiro, Anthony DelleDonne, Joshua Menke, Zeshan Ahmed, Kevin J Klos

Acta Neuropathol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
Andrew McKeon, Keith A Josephs, Kevin J Klos, Kathleen Hecksel, James H Bower

Parkinsonism Relat Disord· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-onset familial parkinsonism due to POLG mutations.
Guido Davidzon, Paul Greene, Michelangelo Mancuso, Kevin J Klos, J Eric Ahlskog

Ann Neurol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unilateral asterixis after thalamic hemorrhage.
Kevin J Klos, Eelco F M Wijdicks

Neurology· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-synuclein immunohistochemistry in two cases of co-occurring idiopathic Parkinson's disease and motor neuron disease.
Kevin J Klos, Keith A Josephs, Joseph E Parisi, Dennis W Dickson

Mov Disord· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological gambling caused by drugs used to treat Parkinson disease.
M Leann Dodd, Kevin J Klos, James H Bower, Yonas E Geda, Keith A Josephs

Arch Neurol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
Kevin J Klos, James H Bower, Keith A Josephs, Joseph Y Matsumoto, J Eric Ahlskog

Parkinsonism Relat Disord· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity.
Kevin J Klos, J Eric Ahlskog, Keith A Josephs, Robert D Fealey, Clayton T Cowl

Arch Neurol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain metastases.
Kevin J Klos, Brian Patrick O'Neill

Neurologist· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Takayasu's arteritis with arteriographic evidence of intracranial vessel involvement.
Kevin Klos, Kelly D Flemming, George W Petty, Harvinder S Luthra

Neurology· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis